December 3, 2024

Giving Tuesday 2024

Become a Member of UsAgainstAlzheimer’s this Giving Tuesday and DOUBLE YOUR IMPACT in the fight to stop Alzheimer’s. Nothing we do would be possible without the support of compassionate donors and advocates like you. That is why we hope you will support us on Giving Tuesday and make a gift today.

The BrainGuide Speech-Based Cognition Tool

BrainGuide’s new speech assessment tool will help you highlight potential cognitive concerns and provide next steps in your brain health journey.

Join the UsAgainstAlzheimer's Membership Program

Become a Member of UsAgainstAlzheimer's today and join a movement of people who don’t just talk about the Alzheimer’s crisis, but become part of the solution.

2024 Brain Health Academy

UsAgainstAlzheimer’s is bringing back its Brain Health Academy in May 2024. First launched in 2022, the Academy offers a free, comprehensive virtual program designed to equip healthcare providers and wellness professionals with the necessary tools and resources to reduce the risks associated with Alzheimer’s and related dementias. In collaboration with the American Society on Aging, participants will receive free continuing education credits to enhance their professional development and growth. Learn more about how you can access this resource today.

Listen to the BrainStorm Podcast

Featuring conversations with healthcare providers, researchers, authors, experts, caregivers, and more, BrainStorm is breaking through the silence of Alzheimer's disease. Tune in on the first and third Tuesdays of every month for a new episode, with our host, Meryl Comer.

Members of Congress Call for More Action on Alzheimer’s

Klobuchar, Warner, Cole, and LaHood discuss progress and the path forward during National Alzheimer’s Summit

Giving Tuesday

Let Your Voice Be Your Guide

Become a Member

2024 Brain Health Academy

Listen to the BrainStorm Podcast

Members of Congress Call for More Action on Alzheimer’s

UsAgainstAlzheimer’s is engaged in a relentless pursuit to end Alzheimer’s, the sixth leading killer in America. Our work centers on prevention, early detection and diagnosis, and access to treatments – all regardless of gender, race, or ethnicity. To achieve our mission, we give voice to patients and caregivers while partnering with government, scientists, the private sector, and allied organizations -- the people who put the “Us” in UsAgainstAlzheimer’s.

Prevention

Alzheimer’s is not a normal part of aging. There are things we can all do to reduce our risk, like eating a healthy diet, exercising, and getting good sleep. People need to know what’s good for the body is good for the brain. Learn more about our prevention work and how you can take charge of your brain health.

CLICK HERE FOR MORE INFO

Early Detection & Diagnosis

Early detection and diagnosis give people a better chance of managing the disease. On top of that, current treatments are most effective with patients in the early stages of dementia.

Find out how we are raising awareness of the importance of early detection and how BrainGuide is helping people concerned about their brain health start a conversation with their doctor.

CLICK HERE FOR MORE INFO

Access to Treatments

We are working on multiple fronts to get safe and effective treatments into the hands of people who need them most. That includes working to ensure Alzheimer’s patients are treated fairly as the federal government considers drug approval and Medicare coverage for treatments.

See how else UsAgainstAlzheimer’s is fighting for access to treatments.

CLICK HERE FOR MORE INFO

 

Center for Brain Health Equity

Most Alzheimer’s patients are women, Latinos, and Black people. As a patient-centered organization, all our work is done with equity in mind, so we are addressing needs of the people who are most heavily impacted by the disease. Learn more about how UsAgainstAlzheimer’s Center for Brain Health Equity is working toward a healthcare system that works for everyone.

Recent News and Blog Posts

  • July 06, 2023

    UsAgainstAlzheimer’s Applauds FDA Approval of Leqembi for Treatment of Early-Stage Alzheimer’s

    Medicare must now provide coverage for patients.

    Read more
  • June 13, 2023

    UsAgainstAlzheimer's Applauds Unanimous Leqembi Endorsement by FDA Advisory Committee and Encourages Speedy Access for Patients

    The Food and Drug Administration’s (FDA) Peripheral and Central Nervous System Drugs...

    Read more
  • June 01, 2023

    UsAgainstAlzheimer’s Statement on CMS Announcement of Registry for Access to FDA-Approved Alzheimer’s Treatments

    UsAgainstAlzheimer’s greeted the Centers for Medicare & Medicaid Services (CMS) potential approach...

    Read more
  • May 23, 2023

    New Poll: Huge Majorities Want Medicare to Cover Cost of Alzheimer’s Drugs

    Americans want Congress and the president to step in if CMS doesn’t...

    Read more
  • May 11, 2023

    Patients and Caregivers Now Have Option for Treating Alzheimer’s-Related Agitation

    Alzheimer’s patients, caregivers, and advocates are applauding the decision by the Food...

    Read more
  • May 03, 2023

    More Promising News for People Living with Alzheimer's

    Patients Cheer Phase 3 clinical trials showing new drug slows decline compared...

    Read more

Reports

  • Resources

    2022 Annual Report

  • Resources
    alist 2023

    A-LIST Pulse of the Community – July 2023

  • Resources

    A-LIST Pulse of the Community – November 2022